{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:05:22Z","timestamp":1792850722130,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jaci.2024.11.011","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T01:56:44Z","timestamp":1731722204000},"page":"24-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Anti-IgE therapy in chronic rhinosinusitis with nasal polyps"],"prefix":"10.1016","volume":"155","author":[{"given":"Krishan D.","family":"Chhiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju T.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2024.11.011_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European position paper on rhinosinusitis and nasal polyps, 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2024.11.011_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/all.13042","article-title":"Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample","volume":"72","author":"Hirsch","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib3","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jaci.2018.12.986","article-title":"Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology","volume":"143","author":"Dietz de Loos","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/28.4.717","article-title":"Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study","volume":"28","author":"Hedman","year":"1999","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jaci.2024.11.011_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/000348940311200709","article-title":"Prevalence of nasal polyps in adults: the Skovde population-based study","volume":"112","author":"Johansson","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaci.2024.11.011_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1398-9995.2005.00688.x","article-title":"Prevalence of nasal polyposis in France: a cross-sectional, case\u2013control study","volume":"60","author":"Klossek","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib7","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaip.2018.10.014","article-title":"Clinical characteristics of patients with chronic rhinosinusitis without nasal polyps in an academic setting","volume":"7","author":"Benjamin","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.11.011_bib8","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/lary.27852","article-title":"Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps","volume":"129","author":"Bhattacharyya","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2024.11.011_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11882-017-0690-5","article-title":"Economics of chronic rhinosinusitis","volume":"17","author":"Rudmik","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2024.11.011_bib10","first-page":"343","article-title":"The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life","volume":"57","author":"Khan","year":"2019","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2024.11.011_bib11","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3109\/00016489.2010.539625","article-title":"Effects of smell loss on daily life and adopted coping strategies in patients with nasal polyposis with asthma","volume":"131","author":"Nordin","year":"2011","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.jaci.2024.11.011_bib12","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/cea.14157","article-title":"Loss of smell in patients with aspirin-exacerbated respiratory disease impacts mental health and quality of life","volume":"52","author":"Tchekmedyian","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0091-6749(97)70091-5","article-title":"Nasal polyposis: immunohistochemistry and bioelectrical findings (a hypothesis for the development of nasal polyps)","volume":"99","author":"Bernstein","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib14","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/archotol.132.12.1352","article-title":"Potential role of abnormal ion transport in the pathogenesis of chronic sinusitis","volume":"132","author":"Dejima","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2024.11.011_bib15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jaci.2012.05.052","article-title":"Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-gamma and IL-4","volume":"130","author":"Soyka","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib16","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.11.011_bib17","doi-asserted-by":"crossref","first-page":"873","DOI":"10.12998\/wjcc.v2.i12.873","article-title":"Eosinophilic chronic rhinosinusitis in East Asians","volume":"2","author":"Wang","year":"2014","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jaci.2024.11.011_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0194599813495363","article-title":"Changes in histological features of nasal polyps in a Korean population over a 17-year period","volume":"149","author":"Kim","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2024.11.011_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/alr.22234","article-title":"Changes in the clinical and histological characteristics of Chinese chronic rhinosinusitis with nasal polyps over 11 years","volume":"9","author":"Wang","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2024.11.011_bib20","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1111\/all.13552","article-title":"Epithelial activators of type 2 inflammation: elevation of thymic stromal lymphopoietin, but not IL-25 or IL-33, in chronic rhinosinusitis with nasal polyps in Chicago, Illinois","volume":"73","author":"Ogasawara","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jaci.2013.04.005","article-title":"Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis","volume":"132","author":"Nagarkar","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib22","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jaci.2022.02.016","article-title":"Mechanisms and pathogenesis of chronic rhinosinusitis","volume":"149","author":"Kato","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.01.043","article-title":"Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression","volume":"131","author":"Hulse","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jaci.2015.07.025","article-title":"Nasal IL-4+CXCR5+CD4+ T follicular helper cell counts correlate with local IgE production in eosinophilic nasal polyps","volume":"137","author":"Zhang","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib25","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jaci.2008.03.002","article-title":"Evidence of a role for B cell\u2013activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps","volume":"121","author":"Kato","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/all.12054","article-title":"Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps","volume":"68","author":"Gevaert","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib27","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jaci.2020.02.035","article-title":"IL-5Ralpha marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease","volume":"145","author":"Buchheit","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib28","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaci.2010.07.007","article-title":"Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma","volume":"126","author":"Bachert","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib29","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jaci.2008.02.018","article-title":"T-cell regulation in chronic paranasal sinus disease","volume":"121","author":"Van Bruaene","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb7221","article-title":"Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation","volume":"6","author":"Dwyer","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaci.2021.02.045","article-title":"Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesis","volume":"148","author":"Stevens","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib32","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaci.2011.08.037","article-title":"Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps","volume":"128","author":"Tan","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib33","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/j.1365-2222.2007.02838.x","article-title":"Local immunoglobulin production in nasal polyposis is modulated by superantigens","volume":"37","author":"Van Zele","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib34","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1067\/mai.2001.112374","article-title":"Total and specific IgE in nasal polyps is related to local eosinophilic inflammation","volume":"107","author":"Bachert","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1398-9995.2010.02448.x","article-title":"Mucosal tissue polyclonal IgE is functional in response to allergen and SEB","volume":"66","author":"Zhang","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s12016-021-08901-1","article-title":"The role of IgE in upper and lower airway disease: more than just allergy!","volume":"62","author":"Gevaert","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/19458924221147770","article-title":"B Lineage cells and IgE in allergic rhinitis and CRSwNP and the role of omalizumab treatment","volume":"37","author":"Bai","year":"2023","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib39","first-page":"45","article-title":"Local IgE production in nonatopic nasal polyposis","volume":"39","author":"Sheahan","year":"2010","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2024.11.011_bib40","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1097\/00005537-200410000-00027","article-title":"Immunoglobulin E to staphylococcal and streptococcal toxins in patients with chronic sinusitis\/nasal polyposis","volume":"114","author":"Tripathi","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2024.11.011_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/194589240501900401","article-title":"Staphylococcal exotoxins and nasal polyposis: analysis of systemic and local responses","volume":"19","author":"Tripathi","year":"2005","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2024.11.011_bib42","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1034\/j.1398-9995.2002.02156.x","article-title":"Staphylococcus aureus enterotoxins: a key in airway disease?","volume":"57","author":"Bachert","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009525","article-title":"Screening for staphylococcal superantigen genes shows no correlation with the presence or the severity of chronic rhinosinusitis and nasal polyposis","volume":"5","author":"Heymans","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2024.11.011_bib44","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jaci.2004.07.013","article-title":"Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis","volume":"114","author":"Van Zele","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2500\/105065801781329365","article-title":"Nasal polyposis and allergy: is there a correlation?","volume":"15","author":"Voegels","year":"2001","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2024.11.011_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40136-020-00287-6","article-title":"Updates to the current understanding of the relationship between allergy and chronic sinusitis","volume":"8","author":"Brook","year":"2020","journal-title":"Curr Otorhinolaryngol Rep"},{"key":"10.1016\/j.jaci.2024.11.011_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1081-1206(10)62807-4","article-title":"Does inhaled pollen enter the sinus cavities?","volume":"81","author":"Adkins","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2500\/ajra.2013.27.3906","article-title":"Chronic sinusitis pathophysiology: the role of allergy","volume":"27","author":"Kennedy","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib49","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jaci.2022.04.010","article-title":"Autoimmune chronic spontaneous urticaria","volume":"149","author":"Kolkhir","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jaci.2003.11.044","article-title":"Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils","volume":"113","author":"Lin","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2045-7022-3-29","article-title":"Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells","volume":"3","author":"Chan","year":"2013","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib52","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1398-9995.2006.01180.x","article-title":"Omalizumab decreased IgE-release and induced changes in cellular immunity in patients with allergic asthma","volume":"61","author":"Hanf","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib53","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4049\/jimmunol.157.2.607","article-title":"Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation","volume":"157","author":"Maurer","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jaci.2023.10.014","article-title":"Little to no mRNA for the alpha- or beta-chains of FcepsilonRI in human eosinophils","volume":"153","author":"Chhiba","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib55","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/0003489417731782","article-title":"Anti-IgE and anti-IL5 biologic therapy in the treatment of nasal polyposis: a systematic review and meta-analysis","volume":"126","author":"Rivero","year":"2017","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaci.2024.11.011_bib56","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib57","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2500\/ajr.2007.21.3060","article-title":"The role of anti-IgE immunoglobulin therapy in nasal polyposis: a pilot study","volume":"21","author":"Penn","year":"2007","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2024.11.011_bib58","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4193\/Rhino09.144","article-title":"A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis","volume":"48","author":"Pinto","year":"2010","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2024.11.011_bib59","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.anai.2013.01.024","article-title":"Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma","volume":"110","author":"Tajiri","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib60","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/thx.2010.152835","article-title":"Efficacy of omalizumab in the treatment of nasal polyps","volume":"66","author":"Vennera Mdel","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2024.11.011_bib61","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jaip.2019.02.030","article-title":"IgE-mediated multimorbidities in allergic asthma and the potential for omalizumab therapy","volume":"7","author":"Humbert","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.11.011_bib62","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jaci.2016.03.045","article-title":"Staphylococcal serine protease-like proteins are pacemakers of allergic airway reactions to Staphylococcus aureus","volume":"139","author":"Stentzel","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib63","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib64","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/alr.23322","article-title":"Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps: an analysis of randomized clinical trials","volume":"14","author":"Meltzer","year":"2024","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2024.11.011_bib65","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jaci.2019.02.001","article-title":"Broad IgG repertoire in patients with chronic rhinosinusitis with nasal polyps regulates proinflammatory IgE responses","volume":"143","author":"Shamji","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib66","first-page":"736","article-title":"Local specific IgE production in nasal polyps associated with negative skin tests and serum RAST","volume":"55","author":"Small","year":"1985","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/19458924211030486","article-title":"Defining the efficacy of omalizumab in nasal polyposis: a POLYP 1 and POLYP 2 subgroup analysis","volume":"36","author":"Damask","year":"2022","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib68","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.anai.2023.11.001","article-title":"Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status","volume":"132","author":"Gevaert","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib69","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaci.2023.09.041","article-title":"IgE directly affects eosinophil\u00a0migration in chronic rhinosinusitis with nasal polyps through CCR3 and predicts the efficacy of omalizumab","volume":"153","author":"Yu","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib70","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jaci.2021.08.015","article-title":"Eicosanoid dysregulation and type 2 inflammation in AERD","volume":"148","author":"Mullol","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib71","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaci.2021.07.045","article-title":"Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study","volume":"149","author":"Gevaert","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib72","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.anai.2018.05.007","article-title":"Omalizumab can inhibit respiratory reaction during aspirin desensitization","volume":"121","author":"Lang","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib73","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1164\/rccm.201906-1215OC","article-title":"Omalizumab for aspirin hypersensitivity and leukotriene overproduction in aspirin-exacerbated respiratory disease. A\u00a0randomized controlled trial","volume":"201","author":"Hayashi","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.11.011_bib74","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.jaci.2023.03.014","article-title":"Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease","volume":"151","author":"Hayashi","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib75","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaci.2019.05.019","article-title":"Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort","volume":"145","author":"Namazy","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib76","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3390\/jpm13071068","article-title":"Long-term safety of omalizumab in children with asthma and\/or chronic spontaneous urticaria: a 4-year prospective study in real life","volume":"13","author":"Galletta","year":"2023","journal-title":"J Pers Med"},{"key":"10.1016\/j.jaci.2024.11.011_bib77","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2147\/JAA.S363398","article-title":"Efficacy and safety of omalizumab treatment over a 16-year follow-up: when a clinical trial meets real-life","volume":"15","author":"Menzella","year":"2022","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaci.2024.11.011_bib78","article-title":"Xolair\u00ae (omalizumab for subcutaneous use) package insert","year":"2024","journal-title":"South San Francisco, Calif"},{"key":"10.1016\/j.jaci.2024.11.011_bib79","first-page":"194","article-title":"EPOS\/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps, 2023","volume":"61","author":"Fokkens","year":"2023","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2024.11.011_bib80","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jaci.2021.09.009","article-title":"Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis","volume":"149","author":"Oykhman","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib81","article-title":"Perioperative adjuvant therapy with short course of dupilumab with ESS for recurrent CRSwNP","author":"Pelletier","year":"2024","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2024.11.011_bib82","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11882-023-01106-w","article-title":"Omalizumab treatment in uncontrolled asthma and CRSwNP patients, with previous endoscopic sinus surgery, to improve quality of life and endoscopic outcomes: a two-year real-life study","volume":"23","author":"Maza-Solano","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2024.11.011_bib83","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jaci.2022.10.026","article-title":"The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis","volume":"151","author":"Rank","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.011_bib84","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.jaip.2021.01.031","article-title":"Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps","volume":"9","author":"Peters","year":"2021","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924012156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924012156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T19:50:26Z","timestamp":1750708226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674924012156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0091674924012156"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.11.011","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-IgE therapy in chronic rhinosinusitis with nasal polyps","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}